TRMT6, TRMT10C, and YTHDF1 are expressed at higher levels in HCC than in normal tissues and are associated with poor prognosis in HCC and could be used as prognostic biomarkers in HCC (Wang et al., 2019; Shi et al., 2020b). This evidence concerns the gene TRMT10C and hepatocellular carcinoma.